简介：

简介：FromJuly7to17in2009,the1stSino-GermanInt’lSymposiumonacupuncture&moxibustionwasheldinChengdu.Thirtywell-knownexpertsfromChina,Germany,theUnitedStates,Switzerlandandothercountrieshadathoroughexchangeanddiscussiononacupunctureandmoxibustionclinicalresearchandfuturetrends.Themaincontentsofthemeetingaresummarizedasfollows

简介：OnNovember15,2015,theAwardCeremonyof'2015internationalphotocontestofTCMacupuncturemoxibustion'washeldinBeijing,ChinabyHeadquartersoftheWorldFederationofAcupuncturemoxibustionSocieties(WFAS),congratulatingthe5thanniversarycelebrationofsuccessfulapplicationforthelistofworldheritageof'TCMacupuncturemoxibustion'and'Worldacupuncture-moxibustionweek'seriesofactivitiesof

简介：本文探讨了21世纪中医针灸国际发展十大趋势与战略思考：①立法是中医针灸国际化发展的必然趋势;②中医理论、临床、剂型改革将成为重要研究课题;③中医药针灸国际标准化将＂求同存异＂;④海外中医针灸队伍将不断壮大和优化;⑤海外中医医疗机构将逐步整合与扩大;⑥中医药针灸知识产权的保护将受到重视;⑦海外中医针灸教育与学习方式将多元化发展;⑧中医针灸手法的传承将＂不可替代＂;⑨互联网等高科技及风投更加促进中医针灸国际化;⑩崛起的中国将助力中医药针灸国际化。

简介：Asthelargestinternationalstandardsdevelopmentorganization,theInternationalOrganizationforStandardization(ISO)providesastructurefordevelopinginternationalstandardsoverahugerangeofindustrysectorsandthesestandardsaregloballyrespectedandutilized.Moreover,throughmanyimportantprocessesincludingtheconsensusapproach,ISOstandardscanassistinputtingintoplaceinternationallyagreed

简介：

简介：

简介：

简介：WFASInternationalAcupunctureConferencewasheldfrom25to27September2015attheInternationalPlazaHotel,Toronto,Ontario,Canada.Thisconferencewasco-sponsoredbyWorldFederationofAcupunctureMoxibustionSocieties(WFAS)andChinaAcademyofChineseMedicalSciences(CACMS),organizedbytheChineseMedicineandAcupunctureAssociationofCanada(CMAAC),andsupportedbyChinaAssociationof

简介：ISO18746:2016TraditionalChineseMedicine–SterileintradermalacupunctureneedlesforsingleusehasbeenpublishedonAugust15,2016.(http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=63263)ISO18746:2016specifiestherequirementsofsterileintradermalacupunctureneedleforsingleuseasa

简介：目的：探讨醒脑开窍针刺治疗脑梗死恢复期的远期疗效及安全性。方法：脑梗死恢复期患者234例，以SAS编码，随机分配到醒脑开窍针刺组和常规针刺组（简称醒脑组和常规组）。醒脑组116例，接受醒脑开窍针剌（每日1次，共4周）和西医常规治疗；常规组118例，接受常规针刺和西医常规治疗。随访6个月。主要指标：随访期末生存、治疗和复发情况。次要指标：随访期末神经功能评估，针刺过程中不良事件发生率。结果：6个月随访时醒脑组病死率（0．86％）、继续治疗率（36．21％）与常规组（1．69％、36．44％）差异无统计学意义（X^2=0．29，P=0．59；X^2=0.32，P=0．57），在降低复发率、改善神经功能方面醒脑组优于常规组（P〈0．01）；两组均未出现严重不良反应。结论：醒脑开窍针刺是安全的，其远期疗效在降低复发率、改善神经功能方面优于常规针刺。